Abstract
Women and girls with complete androgen insensitivity syndrome (CAIS) invariably have a female typical core gender identity. In this case report, we describe the first case of male gender identity in a CAIS individual raised female leading to complete sex reassignment involving both androgen treatment and phalloplasty. CAIS was diagnosed at age 17, based on an unambiguously female phenotype, a 46,XY karyotype, and a 2660delT androgen receptor (AR) gene mutation, leading to a premature stop in codon 807. Bilateral gonadectomy was performed but a short period of estrogen treatment induced a negative emotional reaction and treatment was stopped. Since the age of 3, childhood-onset cross gender behavior had been noticed. After a period of psychotherapy, persisting male gender identity was confirmed. There was no psychiatric co-morbidity and there was an excellent real life experience. Testosterone substitution was started, however without inducing any of the desired secondary male characteristics. A subcutaneous mastectomy was performed and the patient received phalloplasty by left forearm free flap and scrotoplasty. Testosterone treatment was continued, without inducing virilization, and bone density remained normal. The patient qualifies as female-to-male transsexual and was treated according to the Standards of Care by the World Professional Association for Transgender Health with good outcome. However, we do not believe that female sex of rearing as a standard procedure should be questioned in CAIS. Our case challenges the role of a functional AR pathway in the development of male gender identity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Appari, M., Werner, R., Wünsch, L., Cario, G., Demeter, J., Hiort, O., et al. (2009). Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. Journal of Molecular Medicine, 87, 623–632.
Avila, D. M., Wilson, C. M., Nandi, N., Griffin, J. E., & McPhaul, M. J. (2002). Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays. Journal of Clinical Endocrinology and Metabolism, 87, 182–188.
Baldazzi, L., Baroncini, C., Pirazzoli, P., Balsamo, A., Capelli, M., Marchetti, G., et al. (1994). Two mutations causing complete androgen insensitivity: A frame-shift in the steroid binding domain and a Cys → Phe substitution in the second zinc finger of the androgen receptor. Human Molecular Genetics, 3, 1169–1170.
Cheikhelard, A., Morel, Y., Thibaud, E., Lortat-Jacob, S., Jaubert, F., Polak, M., et al. (2008). Long-term follow-up and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. Journal of Urology, 180, 1496–1501.
Chung, H. W., Kim, S. C., & Kim, H. L. (1998). Frame-shift mutation in hormone binding domain of human androgen receptor gene causes complete androgen insensitivity. Molecules and Cells, 8, 741–745.
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008). Non-genomic actions of androgens. Frontiers in Neuroendocrinology, 29, 169–181.
Hannema, S. E., Scott, I. S., Hodapp, J., Martin, H., Coleman, N., Schwabe, J. W., et al. (2004). Residual activity of mutant androgen receptors explains Wolffian duct development in the complete androgen insensitivity syndrome. Journal of Endocrinology and Metabolism, 89, 5815–5822.
Hines, M., Ahmed, S. F., & Hughes, I. A. (2003). Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Archives of Sexual Behavior, 32, 93–101.
Hiort, O., Sinnecker, G. H., Holterhus, P. M., Nitsche, E. M., & Kruse, K. (1998). Inherited and de novo androgen receptor gene mutations: Investigation of single-case families. Journal of Pediatrics, 132, 939–943.
Holterhus, P. M., Brüggenwirth, H. T., Hiort, O., Kleinkauf-Houcken, A., Kruse, K., Sinnecker, G. H., et al. (1997). Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 3584–3589.
Holterhus, P. M., Wiebel, J., Sinnecker, G. H., Brüggenwirt, H. T., Sippell, W. G., Brinkmann, A. O., et al. (1999). Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome. Pediatric Research, 46, 684–690.
Jürgensen, M., Hiort, O., Holterhus, P.-M., & Thyen, U. (2007). Gender role behavior in children with XY karyotype and disorders of sex development. Hormones and Behavior, 51, 443–453.
Kulshreshtha, B., Philibert, P., Eunice, M., Khandelwal, S. K., Mehta, M., Audran, F., et al. (2009). Apparent male gender identity in a patient with complete androgen insensitivity syndrome [Letter to the Editor]. Archives of Sexual Behavior, 38, 873–875.
Mazur, T. (2005). Gender dysphoria and gender change in androgen insensitivity or micropenis. Archives of Sexual Behavior, 34, 411–421.
Meyer, W., Bockting, W. O., Cohen-Kettenis, P., Coleman, E., DiCeglie, D., Devor, H., et al. (2001). The standards of care for gender identity disorders—Sixth version. Journal of Psychology and Human Sexuality, 13, 1–30.
Meyer-Bahlburg, H. F. L. (2009). Concerns regarding gender change to male in a 46,XY child with complete androgen insensitivity syndrome: Comment on Kulshreshtha et al. (2009) [Letter to the Editor]. Archives of Sexual Behavior, 38, 876–877.
Money, J. (1991). Biographies of gender and hermaphroditism in paired comparisons. Amsterdam: Elsevier.
Monstrey, S., Hoebeke, P., Selvaggi, G., Ceulemans, P., Van Landuyt, K., Blondeel, P., et al. (2009). Penile reconstruction: Is the radial forearm flap really the standard technique? Plastic and Reconstructive Surgery, 124, 510–518.
Mordaunt, M. (2006). Pitch and intonation. In R. K. Adler, S. Hirsch, & M. Mordaunt (Eds.), Voice and communication therapy for the transgender/transsexual client: A comprehensive clinical guide (pp. 169–207). San Diego, CA: Plural Publishing.
Rodien, P., Mebarki, F., Mowszowicz, I., Chaussain, J. L., Young, J., Morel, Y., et al. (1996). Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. Journal of Clinical Endocrinology and Metabolism, 81, 2994–2998.
Sato, T., Matsumoto, T., Kawano, H., Watanabe, T., Uematsu, Y., Sekine, K., et al. (2004). Brain masculinization requires androgen receptor function. Proceedings of the National Academy of Sciences of the United States of America, 101, 1673–1678.
Soriano Guillen, L., Muñoz Calvo, M. T., Martinez Pérez, J., Pozo-Roman, J., Marin-Sobrino, M. A., Gonzalez Medeiro, I., et al. (2002). Deletion of thymine at position 2298 in exon 5 of the androgenic receptor gene causing complete androgen insensitivity syndrome. Anales españoles de pediatria, 56, 347–352.
Wisniewski, A. B., Migeon, C. J., Meyer-Bahlburg, H. F. L., Gearhart, J. P., Berkovitz, G. D., Brown, T. R., et al. (2000). Complete androgen insensitivity syndrome: Long-term medical, surgical, and psychosexual outcome. Journal of Clinical Endocrinology and Metabolism, 85, 2664–2669.
Acknowledgement
Martine Cools is supported by the Flanders Research Foundation (FWO).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
T’Sjoen, G., De Cuypere, G., Monstrey, S. et al. Male Gender Identity in Complete Androgen Insensitivity Syndrome. Arch Sex Behav 40, 635–638 (2011). https://doi.org/10.1007/s10508-010-9624-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-010-9624-1